ILLUMINA, INC.
SAN DIEGO, CA

ILLUMINA, INC., SAN DIEGO

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. © 2018 Illumina, Inc. All rights reserved. All trademarks are the property of Illumina, Inc. or their respective owners. We are beginning to unlock the power of the genome – to transform healthcare and beyond About Illumina As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new world, and showed us how much further there is to go. While the rate of progress is accelerating exponentially, we are only beginning to understand the clinical significance of the genome. What causes a cancer cell to mutate? What is the origin of a puzzling disease? Is it possible to prevent the next outbreak? Or safeguard the world’s food supply? These are just a few of the challenges that inspire us to push the boundaries of our imagination. Making a difference now Today we are a global leader in genomics – an industry at the intersection of biology and technology. At the most fundamental level, we enable our customers to read and understand genetic variations. We strive to make our solutions increasingly simple, more accessible, and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment. Company profile At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. © 2018 Illumina, Inc. All rights reserved. All trademarks are the property of Illumina, Inc. or their respective owners. About Illumina Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With rapid advances in technology taking place, it is mission-critical to offer solutions that are not only innovative, but flexible, and scalable, with industry-leading support and service. The Illumina vision Illumina is a global company with a vision to be the leading provider of integrated solutions that advance the understanding of genetics and health. Our goal is to improve human health by enabling our customers to accelerate the collection, analysis, and application of biological information. Leading-edge products and services Illumina has developed a comprehensive line of products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. Our broad portfolio of leading-edge sequencing and array-based solutions address a range of genomic complexity and throughput, enabling researchers to select the best solution for their scientific challenge. VanBrocklin family finds answers with cWGS provided by iHope Program Illumina in the Community Through our various outreach programs, we strive to connect our employees to the communities in which they live and work. When we look to partner with organizations from each of our core focus areas, we provide opportunities for our employees to actively participate. This ensures we are making a meaningful impact. Students visit the Illumina global headquarters for a campus tour and career immersion activities Illumina Proxy At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. © 2018 Illumina, Inc. All rights reserved. All trademarks are the property of Illumina, Inc. or their respective owners. Dylan Pricket, from Poway, has his photo taken dressed as a scientist courtesy of an Illumina booth during the 2017 San Diego Festival of Science & Engineering. Dylan Pricket, from Poway, has his photo taken dressed as a scientist courtesy of an Illumina booth during the 2017 San Diego Festival of Science & Engineering. (Nancee Lewis Photography) Fifteen years ago, genomics was a distant dream. The idea that we could quickly and accurately decipher the billions of letters in a person’s genetic code seemed like science fiction to most people. But now it’s become relatively routine. Cancer patients get genomic tests to determine which treatments will work best for their particular disease. Forensic scientists use DNA every day to help solve crimes. Millions of people send their DNA to ancestry.com to learn more about their origins.

KEY FACTS ABOUT ILLUMINA, INC.

Company name
ILLUMINA, INC.
Status
Active
Filed Number
F10000005154
FEI Number
330804655
Date of Incorporation
November 2, 2010
Age - 14 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://illumina.com
Phones
(858) 202-4500
(858) 202-4545
(858) 882-2172
(858) 882-6822
(800) 809-4566
(858) 202-4566
(858) 202-4766
(400) 066-5835
(800) 101-4940
(893) 803-5677
(180) 093-6608
(800) 022-2493
(800) 012-6019
(207) 305-7197
(858) 882-2080
(800) 251-4215
(800) 284-8474
(608) 258-3080
(608) 258-3088
(650) 204-2200
(408) 861-3610
(408) 861-3630
(650) 632-1680
(800) 579-2745
(866) 457-5467
(250) 483-7011
(250) 483-7777
(510) 670-9300
(510) 670-9302
(662) 350-3090
(662) 350-3080
(632) 584-4762
(128) 801-5745
(507) 224-9705

ILLUMINA, INC. NEAR ME

Principal Address
5200 ILLUMINA WAY,
SAN DIEGO,
CA,
92122

See Also

Officers and Directors

The ILLUMINA, INC. managed by the three persons from SAN DIEGO on following positions: President, Sr., Dire

Francis Desouza

Position
President Active
From
SAN DIEGO, CA, 92122

Joydeep Goswami

Position
Sr. Active
From
SAN DIEGO, CA, 92122

Frances Arnold

Position
Dire Active
From
SAN DIEGO, CA, 92122





Registered Agent is C T CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Annual Reports

2023
March 23, 2023
2022
March 18, 2022